Citigroup’s Response Genetics RGDX Stock Holding History
Bought
Maintained
Sold
Citigroup's RGDX Position: Q3 2015 in Review
Citigroup sold out of Response Genetics (RGDX) in Q3 2015, closing a stake of 53 shares.
Citigroup first reported a position in RGDX in Q2 2013 and held it in 7 quarters. The position peaked at $4K in Q4 2013. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.
- Citigroup reported no remaining Response Genetics position as of Q3 2015 after selling out during the quarter.
- Citigroup sold 53 Response Genetics shares in Q3 2015.
- Citigroup first reported a position in Response Genetics in Q2 2013 and held it in 7 quarters.
- Citigroup's Response Genetics position peaked at $4K in Q4 2013.
- 1 fund tracked by Wall St. Rank held Response Genetics as of Q3 2015.
Based on Citigroup's 13F filing for Q3 2015, filed 13 Nov 2015.